Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled Trial

What is it about?

We show that low-dose self-administered glucagon analog (dasiglucagon) can correct postprandial hypoglycemia within 15 minutes and reduce time spent in hypoglycemia without causing rebound hyperglycemia in gastric bypass operated individuals affected by the complication "post-bariatric hypoglycemia".

Featured Image